Ignite Creation Date:
2024-05-05 @ 12:09 PM
Last Modification Date:
2024-10-26 @ 9:21 AM
Study NCT ID:
NCT00259272
Status:
COMPLETED
Last Update Posted:
2009-06-24
First Post:
2005-11-28
Brief Title:
Validation of Multidimensional Assessment of THYmic States MATHYS A Study in a Population of Bipolar Patients Treated With Olanzapine
Sponsor:
Eli Lilly and Company
Organization:
Eli Lilly and Company
Study Overview
Official Title:
Phase IIIb Multicenter Single-Arm Open-Label Study Supporting the Development and the Validation of the MATHYS Scale Multidimensional Assessment of THYmic States in a Population of Bipolar Patients Treated With Olanzapine Either in-Label Manic and Mixed Patients and Off-Label Hypomanic and Bipolar Depression
Status:
COMPLETED
Status Verified Date:
2009-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
A non randomized study to validate the MATHYS Scale in a population of in and outpatients greater than or equal to 18 years of age suffering from Bipolar Disorder I or II and treated with olanzapine
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| F1D-FP-S057 | None | None | None |